---
title: "Survey: Limited adoption of CKM staging and PREVENT risk tools in U.S. clinics"
id: "aha-news-5-survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools"
canonical_url: "https://medichelpline.com/clinical-feed/aha-news-5-survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "AHA News (American Heart Association)"
source_url: "https://newsroom.heart.org/news/survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools"
published_at: "2026-11-02T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Survey: Limited adoption of CKM staging and PREVENT risk tools in U.S. clinics
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/aha-news-5-survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** AHA News (American Heart Association)
- **Source URL:** [Original Journal Publication](https://newsroom.heart.org/news/survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools)
- **Published At:** 2026-11-02T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- A baseline survey of 97 clinical sites in the American Heart Association’s Cardiovascular-Kidney-Metabolic Health Initiative documented current use of screening and risk tools for **CKM syndrome**. - Most clinics performed standard screenings for individual CKM components; 75% screened for CKM-related conditions and 73% reported systematic testing for CKM risk factors. - Use of newer, guideline-recommended assessments was low: only 28% of sites used the **PREVENT** equations and 22% used CKM syndrome staging as part of assessment. - Waist circumference was measured routinely at only 22% of sites, despite its relevance to metabolic risk assessment. - Survey respondents were primarily outpatient facilities (92%), with organization types reported as 44% safety-net, 39% non-academic and 16% academic. - The survey captured self-reported implementation status between Aug. 2025 and June 2026 and included clinics selected for initiative participation based on community burden and structural factors. - Study limitations reported by the investigators include incomplete site responses (97 of ~150 enrolled sites), self-reporting bias, and potential selection bias from how sites were chosen for the initiative. - The authors framed the baseline as an opportunity to increase adoption of coordinated CKM assessment and to guide implementation efforts within the AHA initiative. - Abstract status: the findings come from a meeting abstract to be presented at **AHA Scientific Sessions 2026** and are preliminary until peer-reviewed publication.
## Clinical Analysis & Structured Key Points
[Skip Navigation](https://newsroom.heart.org/news/survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools#site_content) [Skip to main content](https://newsroom.heart.org/news/survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools#site_content) * [ Warning Signs ](https://www.heart.org/en/about-us/heart-attack-and-stroke-symptoms) * [ Volunteer ](http://www.heart.org/HEARTORG/volunteer/volunteerForm.jsp) * [ Donate ](https://www2.heart.org/site/SPageNavigator/donatenow_heart.html?s_src=mobile) [ ![return to American Heart Association ](https://www.heart.org/-/media/images/logos/global-do-no-edit/header/aha_icon.svg?h=100&w=200&hash=3022F7F39B2275C85A344A476BED5540263C280C) ](https://www.heart.org/en) [ Newsroom ](https://newsroom.heart.org/) * [![](https://www.heart.org/-/media/feature/navigation/topnav/icon_symptoms.svg?h=19&w=19&hash=A63C8FC4FDBFCB523AA30B93358748A9E553BADE) Heart Attack And Stroke Symptoms ](https://www.heart.org/en/about-us/heart-attack-and-stroke-symptoms) * [![](https://www.heart.org/-/media/feature/navigation/topnav/icon_volunteer.svg?h=24&w=24&hash=D803FE311C9E2131B12D1CAB8DE3EC116DBF43E9) Volunteer ](https://www.heart.org/HEARTORG/volunteer/volunteerForm.jsp) * [![](https://www.heart.org/-/media/feature/navigation/topnav/donateheartwhite.svg?h=20&w=22&hash=20AE6294C88817CD59AF2B5B4013D6446B60E6F1) Donate ](https://www2.heart.org/site/SPageNavigator/donatenow_heart.html?s_src=nav&pagename=%2Fdonatenow_heart&utm_expid=.Gd9MG4GFQjaAcfhuC0-%20%20l4w.0&utm_referrer=https%3A%2F%2Fwww.heart.org%2F) * ![](https://www.heart.org/-/media/project/common/glyphs/search.svg?h=24&w=24&hash=48F9050F2DB090F226BF5F840DE12DC3B8082466)Search × Search Menu [ Newsroom ](https://newsroom.heart.org/) * News Media Access * [News Media Embargoed Access](https://newsroom.heart.org/access/apply) * [Login to Password Protected Newsroom](https://newsroom.heart.org/access/embargoed-news) * [Apply for Embargoed Access](https://newsroom.heart.org/access/apply) * Policies & Resources * [Embargo Policy and Guidelines](https://newsroom.heart.org/policies/embargo-policy) * [American Heart Association Fact Sheets](https://newsroom.heart.org/policies/american-heart-association-fact-sheets) * [American Heart Association News Stories](https://www.heart.org/en/news) * [Boilerplates](https://newsroom.heart.org/policies/boilerplates) * [Copyright Permissions](https://www.heart.org/en/about-us/statements-and-policies/copyright-permission-guidelines) * [Glossary of Scientific Terms](https://newsroom.heart.org/policies/glossary-of-scientific-terms) * [Linking Policy](https://www.heart.org/en/about-us/statements-and-policies/linking-policy) * [Scientific Statements/Guidelines](https://professional.heart.org/professional/GuidelinesStatements/UCM_316885_Guidelines-Statements.jsp) * [Scientific Publications: Purposes-Processes](https://professional.heart.org/professional/GuidelinesStatements/PublicationDevelopment/UCM_475318_Publication-Development.jsp) * [Statistics](https://www.heart.org/en/about-us/heart-and-stroke-association-statistics?uid=1740) * Multimedia Resources * [Multimedia Resources](https://newsroom.heart.org/multimedia) * [Animation/Video](https://newsroom.heart.org/multimedia/animation-video) * [Images/Graphics](https://newsroom.heart.org/multimedia/images-graphics) * [Audio](https://newsroom.heart.org/multimedia/audio) * [Usage Policy](https://newsroom.heart.org/multimedia/usage) * Connect With Us * [Connect With Us](https://newsroom.heart.org/connect/contacts) * [Media Contacts](https://newsroom.heart.org/connect/contacts) * [Consumer/Media Connections](https://newsroom.heart.org/connect/consumer-media-connections) ![Submit Search](https://www.heart.org/-/media/project/common/glyphs/search.svg) * [ Twitter ](https://twitter.com/HeartNews) * [ Facebook ](https://www.facebook.com/AmericanHeart/timeline) * [ YouTube ](http://www.youtube.com/americanheartassoc) * [ RSS ](https://newsroom.heart.org/rss) * [ Email Alerts ](https://newsroom.heart.org/alerts) 1. [Newsroom](https://newsroom.heart.org/) 2. [Search News Releases](https://newsroom.heart.org/news) 3. Survey finds gaps in use of cardiovascular-kidney-metabolic syndrome tools **Categories:** [Heart News](https://newsroom.heart.org/news?c=856), [Scientific Conferences & Meetings](https://newsroom.heart.org/news?c=858) | Published: November 02, 2026 # Survey finds gaps in use of cardiovascular-kidney-metabolic syndrome tools American Heart Association Scientific Sessions 2026, Abstract MDP0261 [ ![facebook](https://newsroom.heart.org/media/themes/5cf02be72cfac21af0e27a3f/fonts/facebook.svg) Facebook ](http://www.facebook.com/sharer.php?u=https://newsroom.heart.org/news/survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools) [ ![twitter](https://newsroom.heart.org/media/themes/5cf02be72cfac21af0e27a3f/fonts/twitter.svg) Twitter ](http://twitter.com/share?text=Survey%20finds%20gaps%20in%20use%20of%20cardiovascular-kidney-metabolic%20syndrome%20tools&url=https://newsroom.heart.org/news/survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools) [ ![facebook](https://newsroom.heart.org/media/themes/5cf02be72cfac21af0e27a3f/fonts/linkedin.svg) LinkedIn ](https://www.linkedin.com/shareArticle?mini=true&url=https://newsroom.heart.org/news/survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools) ![facebook](https://newsroom.heart.org/media/themes/5cf02be72cfac21af0e27a3f/fonts/envelope-fill.svg) Email [ ![facebook](https://newsroom.heart.org/media/themes/5cf02be72cfac21af0e27a3f/fonts/printer-fill.svg) Print ](https://newsroom.heart.org/news/survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools?print=1) **Research Highlights:** * In a survey of almost 100 primary care outpatient facilities and other clinical sites in the U.S., fewer than one-third were using cardiovascular-kidney-metabolic syndrome (CKM syndrome) staging or the PREVENT equations to assess cardiovascular risk. * The survey was a baseline assessment of sites that have joined the American Heart Association’s Cardiovascular-Kidney-Metabolic Health Initiative™, a quality improvement program meant to improve early recognition and management of CKM syndrome. * Standardized screenings for individual components of CKM syndrome were common, while newer protocols for comprehensive CKM syndrome assessment were less common. * The study findings highlight opportunities to improve routine, coordinated heart, kidney and metabolic health screening. * _Note: The study in this news release is a research abstract.__Abstracts presented at American Heart Association’s scientific meetings are not peer-reviewed, and the findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal._ **Embargoed until 4 a.m. CT/5 a.m. ET, Monday, Nov. 2, 2026** DALLAS, Nov. 2, 2026 — In a survey of health clinics participating in a new initiative to improve care for [cardiovascular-kidney-metabolic (CKM) syndrome](https://www.heart.org/en/health-topics/cardiovascular-kidney-metabolic-syndrome/what-is-ckm-syndrome), most sites reported conducting basic screening for heart, kidney and metabolic risks, however, far fewer are using newer [guideline-recommended](https://www.ahajournals.org/doi/10.1161/CIR.0000000000001453) tools such as the CKM syndrome staging framework and the American Heart Association’s [PREVENT](https://professional.heart.org/en/guidelines-and-statements/prevent-calculator)™ (Predicting Risk of cardiovascular EVENT) equations, according to new, preliminary research to be presented at the American Heart Association’s **Scientific Sessions 2026**. The meeting, Nov. 6-9, in Chicago, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. The American Heart Association defines cardiovascular-kidney-metabolic syndrome as a multi-system health disorder due to connections between [obesity](https://www.heart.org/en/health-topics/weight-and-obesity), Type 2 [diabetes](https://www.heart.org/en/health-topics/diabetes), [chronic kidney disease](https://www.heart.org/en/health-topics/diabetes/diabetes-complications-and-risks/kidney-disease--diabetes) and [heart disease](https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease/coronary-artery-disease). Nearly 90% of U.S. adults have at least one of the components of CKM syndrome, including high blood pressure, abnormal cholesterol, high blood glucose (sugar), excess weight, reduced kidney function or related heart conditions. In 2025, the Association launched a [learning collaborative and quality improvement initiative](https://www.heart.org/en/professional/cardiovascular-kidney-metabolic-health) focused on the adoption of a CKM-coordinated care model in about 150 clinical sites across the U.S. Participating sites in the initial launch were selected based on factors such as the burden of CKM syndrome in their community, structural and societal influences, being in rural areas and by the health organization type. All participating clinics were surveyed between Aug. 2025 – June 2026, to document a baseline of the implementation status of the initiative recommendations. A total of 97 clinical sites completed the standardized questionnaire. “We found that most of the sites were actively screening patients for CKM risk factors and related conditions. Far fewer were using specifically recommended clinical assessment tools such as CKM syndrome staging and the PREVENT equations,” said lead author Chiadi Ndumele, M.D., Ph.D., M.H.S., FAHA, director of the Penn Center for Cardiometabolic Heath and Presidential Professor of Medicine at the University of Pennsylvania in Philadelphia. “However, that isn’t entirely surprising. These tools — and even CKM syndrome as a medical condition — embrace relatively new concepts just beginning to be adopted. This baseline is important because it shows we have opportunity to improve patient care as we help clinicians understand how to better incorporate these tools into their practices.” **What are the key findings of this survey?** * 75% of clinical sites screened for CKM-related conditions; * 73% systematically tested patient populations for CKM risk factors; * Only 28% used the PREVENT equations to estimate cardiovascular disease risk; and * Only 22% used CKM syndrome staging. “We see these conditions that define CKM syndrome clustering together — if a person has one condition, they’re more likely to be at risk for the others. Because they are so closely interconnected, we need to look at these all together, which led to this initiative,” Ndumele said. “The baseline assessments highlight areas most requiring targeted focus of implementation efforts to improve CKM syndrome care. Additionally, the details from this analysis inform the blueprint for adoption of evidence-based standards and a CKM model of care and provide evidence to support implementation. These findings could also pave the way for other healthcare sites and hospital systems seeking to improve care for patients with CKM syndrome within their clinical population.” Ndumele said the CKM syndrome stages assessment and the PREVENT equations more closely identify specific risks and opportunities for improved care management. There are four CKM syndrome stages, reflecting the typical evolution of CKM syndrome over time: 1.) Excess or dysfunctional fat which may accumulate around the liver, pancreas, heart and kidneys. 2.) Chronic kidney disease and/or metabolic risk factors 3.) Subclinical heart disease or high-risk equivalents and 4.) clinical heart disease. With early detection and preventive care to reduce progression along CKM syndrome stages, outcomes can improve substantially. The American Heart Association’s PREVENT™ equations, based on contemporary data from more than 6.5 million diverse U.S. adults, have improved accuracy and are more generalizable to U.S. population than previous risk predicting tools. They can estimate 10-year and 30-year risk for cardiovascular disease development for people ages 30-79 without known heart disease, thereby helping to inform the use of preventive therapies. **Study details, background, design and limitations:** * After launching and onboarding novel assessments that screen for heart, kidney and metabolic risks, 97 clinical sites completed a standardized questionnaire to document their status and progress in implementing the new and improved screening and risk estimation tools. * 92% of clinical sites identified as outpatient facilities with the highest representation in primary care; organization types were 44% safety net, 39% non-academic and 16% academic. * Respondents reported which CKM-related screening their clinics currently conduct: social drivers of health screenings (75%), screening for clinical CKM-related comorbidities (75%), and actively screening patient populations for CKM risk factors (73%) were the most performed. * Only 22% of sites reported measuring patients’ waist circumference as standard practice. * Only 28% of sites reported CVD risk estimation via the PREVENT equations, while only 22% reported use of CKM syndrome staging. Study limitations include that although 150 clinical sites are included in the initiative, data from only 97 sites was available at the time of this analysis. The survey represents self-reported data from clinical sites, which is subject to recall bias and potential misclassification. Also clinical sites were chosen by initiative which is subject to selection bias. Ongoing assessments will provide a more comprehensive understanding of the implementation of CKM syndrome practices, as well as related barriers and opportunities, researchers said. “We hope adoption of the newer, more comprehensive tools can help identify patients at higher risk and guide the effective provision of more whole-person care,” Ndumele said. Authors, disclosures and funding sources are listed in the abstract. Statements and conclusions of studies that are presented at the American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. Abstracts presented at the Association’s scientific meetings are not peer-reviewed, rather, they are curated by independent review panels and are considered based on the potential to add to the diversity of scientific issues and views discussed at the meeting. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceuticals, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available [here](https://www.heart.org/en/about-us/aha-financial-information). **Additional Resources:** * Multimedia is available on the right column of the [release link](https://newsroom.heart.org/news/survey-finds-gaps-in-use-of-cardiovascular-kidney-metabolic-syndrome-tools?preview=cc6f662d8dc43b03472bfba0cba7ba9c). * Link to [abstract](https://eppro01.ativ.me/appinfo.php?page=Session&project=AHA26&id=P10319&server=eppro01.ativ.me); and the American Heart Association’s Scientific Sessions 2026 [Online Program Planner ](https://eppro01.ativ.me/web/planner.php?id=AHA26) * American Heart Association news release: [First-ever guideline on cardiovascular-kidney-metabolic syndrome issued](https://newsroom.heart.org/news/first-ever-guideline-on-cardiovascular-kidney-metabolic-syndrome-issued) (June 2026) * American Heart Association news release: [Millions are unaware of heart risks that don’t start in the heart](https://newsroom.heart.org/news/millions-are-unaware-of-heart-risks-that-dont-start-in-the-heart) (Feb. 2026) * American Heart Association news release: [15 regions chosen for groundbreaking effort to reduce cardiovascular disease](https://newsroom.heart.org/news/15-regions-chosen-for-groundbreaking-effort-to-reduce-cardiovascular-disease) (July 2025) * About [Scientific Sessions 2026](https://professional.heart.org/en/meetings/scientific-sessions) * For more news at the American Heart Association’s Scientific Sessions 2026, follow us on X [@HeartNews](https://x.com/HeartNews), #ScientificSessions26 **###** **About the American Heart Association** The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on [heart.org](http://www.heart.org/en), [Facebook](http://facebook.com/AmericanHeart), [X](http://x.com/American_Heart) or by calling 1-800-AHA-USA1. **For Media Inquiries and American Heart Association Expert Perspective:** 214-706-1173 American Heart Association Communications & Media Relations in Dallas: ahacommunications@heart.org Maggie Francis; maggie.francis@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) [heart.org](http://www.heart.org/) and [stroke.org](http://www.stroke.org/) ## Related Images Previous Slide Next Slide [ ![](https://iprsoftwaremedia.com/67/files/20265/b70d51934193d375609fee9bf25d3387/6a1f3ee1d8ee0a1ca9493f81_CKM%20Stages%20Infographic/CKM%20Stages%20Infographic_f7b6d135-01bc-48bd-afd8-0e773d4da785-prv.jpg?v=f7b6d135-01bc-48bd-afd8-0e773d4da785) ](https://newsroom.heart.org/_gallery/get_file/?file_id=6a1f3ee1d8ee0a1ca9493f81&file_ext=.jpeg&page_id=6acbc4593d6332bcc25dc50a&download=true) ### CKM Stages Infographic Infographic: Clinical staging for cardiovascular-kidney-metabolic (CKM) syndrome. [Transcript](https://newsroom.heart.org/_gallery/get_file/?file_id=6a2189d8d8ee0af04d493f81&share=b857ae18ae40865f45ad3d0e7b07d41e&file_ext=.docx) (doc) [News release](https://newsroom.heart.org/news/first-ever-guideline-on-cardiovascular-kidney-metabolic-syndrome-issued?preview=3d45da6c930a1c583e86b583aebde070) copyright American College of Cardiology Foundation and the American Heart Association, Inc. 2026 [Download (210.2 kB)](https://newsroom.heart.org/_gallery/get_file/?file_id=6a1f3ee1d8ee0a1ca9493f81&file_ext=.jpeg&page_id=6acbc4593d6332bcc25dc50a&download=true "CKM Stages Infographic") ![CKM Stages Infographic](https://iprsoftwaremedia.com/67/files/20265/b70d51934193d375609fee9bf25d3387/6a1f3ee1d8ee0a1ca9493f81_CKM%20Stages%20Infographic/CKM%20Stages%20Infographic_f7b6d135-01bc-48bd-afd8-0e773d4da785-prv.jpg?v=f7b6d135-01bc-48bd-afd8-0e773d4da785) # CKM Stages Infographic Infographic: Clinical staging for cardiovascular-kidney-metabolic (CKM) syndrome. [Transcript](https://newsroom.heart.org/_gallery/get_file/?file_id=6a2189d8d8ee0af04d493f81&share=b857ae18ae40865f45ad3d0e7b07d41e&file_ext=.docx) (doc) [News release](https://newsroom.heart.org/news/first-ever-guideline
## Related Clinical Research

- [ZEUS trial: IL-6 blocker ziltivekimab lowered inflammation but did not cut major CV events](https://medichelpline.com/clinical-feed/aha-news-1-researchers-say-inflammation-as-a-treatment-target-still-important-despite.md)
- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)
- [New CKM Health Education Resources Enhance Patient Care for Cardiovascular and Kidney Risks](https://medichelpline.com/clinical-feed/aha-news-2-new-cardiovascular-kidney-metabolic-ckm-health-education-helps-clinicians-turn.md)
- [Embolic Stroke and DOAC Failure in Libman-Sacks Endocarditis with Antiphospholipid Syndrome](https://medichelpline.com/clinical-feed/pubmed-43058350.md) (DOI: 10.1007/s00296-026-06331-w)
- [Medicinal Plants and Diabetic Nephropathy: Phytochemicals, Mechanisms, and Therapeutic Potential](https://medichelpline.com/clinical-feed/frontiers-in-immunology-2-medicinal-plants-in-diabetic-nephropathy-bioactive-compounds-mechanisms-and.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.